Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000901043 | SCV001045390 | likely benign | Combined malonic and methylmalonic acidemia | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000901043 | SCV002805064 | likely benign | Combined malonic and methylmalonic acidemia | 2021-07-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000901043 | SCV001452688 | uncertain significance | Combined malonic and methylmalonic acidemia | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003922963 | SCV004740149 | likely benign | ACSF3-related disorder | 2019-09-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |